Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru

• Autores: Mezones-Holguin E., Canelo-Aybar C., Clark A.D., Janusz C.B., Jaúregui B., Escobedo-Palza S., Hernandez A.V., Vega-Porras D., González M., Fiestas F., Toledo W., Michel F., Suárez V.J.
• Formato: artículo
• Fecha de Publicación: 2015
• Institución: Consejo Nacional de Ciencia Tecnología e Innovación
• Repositorio: CONCYTEC-Institucional
• Lenguaje: inglés
• OAI Identifier: oai:repositorio.concytec.gob.pe:20.500.12390/655
• Enlace del recurso: https://hdl.handle.net/20.500.12390/655; https://doi.org/10.1016/j.vaccine.2014.12.039
• Nivel de acceso: acceso abierto
• Materia: Pneumococcus vaccine; 10-valent pneumococcal conjugate vaccine; 13-valent pneumococcal vaccine; acute otitis media

This study was made possible through the financial support of the Instituto Nacional de Salud (National Institute of Health, Lima, Peru) and the PROVAC Initiative of the Pan American Health Organization (Washington, DC, USA). This study was presented at 9th International Symposium of Pneumococci and Pneumococcal Diseases, Hyderabad, India, March 2014, and supported by the National Council of Science, Technology and Technological Innovation of Peru (CONCYTEC) and International Clinical Epidemiology Network (INCLEN Trust).